Atopic Dermatitis | Sanofi | OBS15333
Pharmaceutical Company/Sponsor:
Sanofi
Code:
OBS15333
Title:
Prospective, Observational, Longitudinal Study in Pediatric Patients With Moderate to Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable.
Type:
Observational
Phase:
Condition/Disease:
Atopic Dermatitis
Intervention(s)/Treatment(s):
Standard of care
Status:
Recruiting
Link for Additional Information:
